Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients.

In the metformin-containing arm, the positive association between circulating follow-up homocysteine and pCR maintained a tendency towards significance (p=0.076) after accounting for tumor size and hormone receptor status ( Table 3 ).

also in 349 other papers